Goldan Keith A. — SEC Form 4 filings
SEC reporting owner CIK 1495411. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-02.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-09 to 2026-06-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 4,250 shares, $25,037 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 11,742 shares, $207,580 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 3,410 shares @ $21.03 ($71,705) in Syndax Pharmaceuticals Inc, filed 2026-02-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 11 | 2 legs · 4,250 sh · $25,037 | 5 legs · 11,742 sh · $207,580 | 14 |
| ABEONA THERAPEUTICS INC. (ABEO) | Director | 1 | — | — | 1 |
Form 4 filings — Goldan Keith A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-02 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Sale (S): 1,177 @ $18.99 | EDGAR |
| 2026-04-07 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 32,751 @ $0 | EDGAR |
| 2026-02-10 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Sale (S): 3,410 @ $21.03 | EDGAR |
| 2026-02-06 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Other (J): 1,219 @ $8.48 · Grant/award (A): 21,500 @ $0 · Grant/award (A): 30,750 @ $0 · Sale (S): 2,082 @ $20.62 · Grant/award (A): 118,000 (derivative) @ $20.43 | EDGAR |
| 2025-12-01 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Gift (G): 1,224 @ $0 | EDGAR |
| 2025-08-07 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Other (J): 1,226 @ $8.43 | EDGAR |
| 2025-07-18 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Sale (S): 1,296 @ $9.29 | EDGAR |
| 2025-05-19 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Purchase (P): 3,000 | EDGAR |
| 2025-02-12 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Sale (S): 3,777 @ $15.50 | EDGAR |
| 2025-02-07 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 18,500 @ $0 · Grant/award (A): 23,400 @ $0 · Grant/award (A): 110,500 (derivative) @ $14.65 | EDGAR |
| 2024-06-17 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Purchase (P): 1,250 @ $20.03 | EDGAR |
| 2024-02-09 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Other (J): 862 @ $18.12 · Other (J): 1,183 @ $17.42 · Grant/award (A): 35,000 @ $0 · Grant/award (A): 11,700 @ $0 · Grant/award (A): 70,000 (derivative) @ $22.28 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1495411 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →